Literature DB >> 15730921

Clinical characteristics and mechanism of liver damage in patients with severe acute respiratory syndrome.

Zhang Yang1, Min Xu, Jun-Qing Yi, Wei-Dong Jia.   

Abstract

BACKGROUND: Abnormal liver function was found in patients with severe acute respiratory syndrome (SARS). This study was undertaken to explore the clinical characteristics and mechanisms of liver damage.
METHODS: The serial laboratory data of liver function test and hepatic histological examination from 168 patients with SARS were retrospectively analyzed.
RESULTS: The abnormalities of serum alanine aminotransferase (ALT) were 52.5%, 71.8%, 85.7% and 85.2%. The average levels of ALT of the patients were 56.07+/-51.57 U/L, 86.46+/-69.93 U/L, 106.69+/-102.50 U/L and 111.32+/-160.24 U/L, and the average levels of serum albumin were 37.25+/-5.37 g/L, 35.82+/-4.74 g/L, 34.49+/-5.04 g/L, and 34.26+/-4.70 g/L, at the day of admission, the first week, second week, and third week after hospitalization, respectively. Significant correlation was not shown among liver damage, blood oxygen saturation (SaO2), degree of fever, and immune functional disorder in this study. Hepatic histological examination of 4 patients demonstrated that non-specific inflammation existed in the liver.
CONCLUSIONS: Liver damage of patients with SARS usually occurs in the early stage of the disease with a high occurrence rate and a prolonged profile, which can be characterized by early, obvious decrease of albumin levels and slightly abnormal levels of ALT. The liver damage induced by SARS seems to be caused by SARS virus directly rather than by low SaO2 or high fever. Hepatotoxic drugs may play a role in increasing the severity of liver damage or prolonging the time of liver function recovery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730921

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  24 in total

1.  Metabolite, protein, and tissue dysfunction associated with COVID-19 disease severity.

Authors:  Ali Rahnavard; Brendan Mann; Abhigya Giri; Ranojoy Chatterjee; Keith A Crandall
Journal:  Sci Rep       Date:  2022-07-16       Impact factor: 4.996

2.  Cautions on the laboratory indicators of COVID-19 patients on and during admission.

Authors:  Haiting Liu; Xueling Shang; Sai Chen; Tie Li; Junhua Zhang
Journal:  J Clin Lab Anal       Date:  2021-05-05       Impact factor: 2.352

3.  COVID-19 Mid-term Impact on Hepatocellular Carcinoma in Patients With Hepatitis C Chronic Infection.

Authors:  Silviu Guler-Margaritis; Adriana Mercan-Stanciu; Letitia Toma; Daniel Rusie; Teodora Isac; Mihai Dodot; Anca Zgura; Nicolae Bacalbasa; Bogdan Haineala; Dumitru Cristinel Badiu; Dragos Serban; Elena Laura Iliescu
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

Review 4.  Liver diseases in COVID-19: Etiology, treatment and prognosis.

Authors:  Jian Wu; Shu Song; Hong-Cui Cao; Lan-Juan Li
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

Review 5.  COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.

Authors:  Michał Kukla; Karolina Skonieczna-Żydecka; Katarzyna Kotfis; Dominika Maciejewska; Igor Łoniewski; Luis F Lara; Monika Pazgan-Simon; Ewa Stachowska; Mariusz Kaczmarczyk; Anastasios Koulaouzidis; Wojciech Marlicz
Journal:  J Clin Med       Date:  2020-05-11       Impact factor: 4.241

6.  Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Ramy Abou Ghayda; Jinhee Lee; Jun Young Lee; Da Kyung Kim; Keum Hwa Lee; Sung Hwi Hong; Young Joo Han; Jae Seok Kim; Jae Won Yang; Andreas Kronbichler; Lee Smith; Ai Koyanagi; Louis Jacob; Jae Il Shin
Journal:  Int J Environ Res Public Health       Date:  2020-07-13       Impact factor: 3.390

7.  Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome.

Authors:  Ronald T K Pang; Terence C W Poon; K C Allen Chan; Nelson L S Lee; Rossa W K Chiu; Yu-Kwan Tong; Ronald M Y Wong; Stephen S C Chim; Sai M Ngai; Joseph J Y Sung; Y M Dennis Lo
Journal:  Clin Chem       Date:  2006-01-19       Impact factor: 8.327

Review 8.  Liver injury in COVID-19: Detection, pathogenesis, and treatment.

Authors:  Yue Cai; Li-Ping Ye; Ya-Qi Song; Xin-Li Mao; Li Wang; Yan-Zhi Jiang; Wei-Tao Que; Shao-Wei Li
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

9.  Animal models and vaccines for SARS-CoV infection.

Authors:  Anjeanette Roberts; Elaine W Lamirande; Leatrice Vogel; Jadon P Jackson; Christopher D Paddock; Jeannette Guarner; Sherif R Zaki; Timothy Sheahan; Ralph Baric; Kanta Subbarao
Journal:  Virus Res       Date:  2007-05-11       Impact factor: 3.303

Review 10.  A brief review of liver injury in patients with Corona Virus Disease-19 during the pandemic.

Authors:  Maham Farshidpour; David Kim; Shilpa Junna; Juanita Merchant
Journal:  Indian J Gastroenterol       Date:  2020-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.